» Articles » PMID: 30221686

MicroRNA-552 Promotes Hepatocellular Carcinoma Progression by Downregulating WIF1

Overview
Journal Int J Mol Med
Specialty Genetics
Date 2018 Sep 18
PMID 30221686
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs/miRs) are involved in the metastasis of hepatocellular carcinoma (HCC). In the present study, it was demonstrated that miR‑552 was upregulated in HCC tissues. High miR‑552 expression was associated with malignant clinicopathological features and decreased survival rates. The in vitro results indicated that miR‑552 overexpression promoted migration, invasion and epithelial‑mesenchymal transition in Hep3B cells. However, the knockdown of miR‑552 inhibited its oncogenic roles in Huh‑7 cells. Additionally, Wnt inhibitory factor 1 (WIF1) was demonstrated to be a direct target of miR‑552 in Hep3B and Huh‑7 cells. Additional experiments identified that miR‑552 promotes β‑catenin expression by increasing the phosphorylation of GSK3β at Ser9. In conclusion, the results suggested that miR‑552 may promote HCC progression by blocking WIF1‑mediated GSK3β dephosphorylation. miR‑552 may be a biomarker for predicting the outcomes of patients with HCC.

Citing Articles

-derived novel-miR1 targets TLR2 to inhibit the immune response in rabbits.

Chen G, Pu G, Wang L, Li Y, Liu T, Li H Front Immunol. 2023; 14:1201455.

PMID: 37559722 PMC: 10408446. DOI: 10.3389/fimmu.2023.1201455.


Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression.

Ahangar Davoodi N, Najafi S, Ghale-Noie Z, Piranviseh A, Mollazadeh S, Ahmadi Asouri S Front Cell Dev Biol. 2023; 10:1065837.

PMID: 36619866 PMC: 9816416. DOI: 10.3389/fcell.2022.1065837.


[Overexpression of miR-607 inhibits hepatocellular carcinoma cell growth and metastasis by down-regulating TRPC5].

Li C, Chen S, Jiang Y Nan Fang Yi Ke Da Xue Xue Bao. 2022; 42(11):1587-1593.

PMID: 36504050 PMC: 9742782. DOI: 10.12122/j.issn.1673-4254.2022.11.01.


miR-340 Promotes Retinoblastoma Cell Proliferation, Migration and Invasion Through Targeting WIF1.

Li K, Han F, Wu Y, Wang X Onco Targets Ther. 2021; 14:3635-3648.

PMID: 34113129 PMC: 8187089. DOI: 10.2147/OTT.S302800.


MicroRNA-552 expression in colorectal cancer and its clinicopathological significance.

Im J, Nam S, Lee H J Pathol Transl Med. 2021; 55(2):125-131.

PMID: 33596633 PMC: 7987523. DOI: 10.4132/jptm.2021.01.17.


References
1.
Liu H, Lei C, He Q, Pan Z, Xiao D, Tao Y . Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer. Mol Cancer. 2018; 17(1):64. PMC: 5822656. DOI: 10.1186/s12943-018-0765-5. View

2.
Gunes Yegin E, Oymaci E, Karatay E, Coker A . Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment. Hepatobiliary Pancreat Dis Int. 2016; 15(3):234-56. DOI: 10.1016/s1499-3872(16)60097-8. View

3.
Chen J, Rajasekaran M, Hui K . Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma. Exp Biol Med (Maywood). 2017; 242(11):1142-1149. PMC: 5478001. DOI: 10.1177/1535370217705865. View

4.
Lou W, Liu J, Gao Y, Zhong G, Chen D, Shen J . MicroRNAs in cancer metastasis and angiogenesis. Oncotarget. 2018; 8(70):115787-115802. PMC: 5777813. DOI: 10.18632/oncotarget.23115. View

5.
Brabletz T, Kalluri R, Nieto M, Weinberg R . EMT in cancer. Nat Rev Cancer. 2018; 18(2):128-134. DOI: 10.1038/nrc.2017.118. View